secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0000318154-26-000054
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen Q1 2026 revenue $8.6B (+6% YoY), Non-GAAP EPS $5.15 (+5% YoY)
-------------------------------------------------------------------

- Total revenue $8.6B (+6% YoY); product sales grew 4% driven by 9% volume growth.
- GAAP EPS $3.34 (+4% YoY); Non-GAAP EPS $5.15 (+5% YoY).
- GAAP operating income $2.7B, margin 32.4% (up 17.4pp); Non-GAAP operating income $3.7B, margin 45.3% (down 0.4pp).
- Free cash flow $1.5B in Q1 2026 vs $1.0B in Q1 2025.
- 16 products achieved double-digit sales growth in Q1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000031815426000054/0000318154-26-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000031815426000054/amgn-20260430.htm
  HTML page:      https://secwatch.observer/filing/0000318154-26-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer